Impact of diabetes mellitus and chronic kidney disease on cardiovascular outcomes and platelet P2Y12 receptor antagonist effects in patients with acute coronary syndromes:insights from the PLATO trial
University of Florida College of Medicine – Jacksonville, Jacksonville (United States of America)
26
presentations
2
followers
9
more
presentations
in this session
Equal safety of rivaroxaban and vitamin K antagonists with regard to the risk of intracranial- and gastrointestinal bleeding in patients with venous thromboembolism - A Danish nationwide study
Efficacy and bleeding risk of newer anticoagulants compared to conventional treatment in patients with chronic kidney disease- a meta analysis of randomized controlled trials
Speaker:
Assistant Professor K. Prudhvi (Tucson, US)